Purchase Order HHSN272201301073P
- Not listed
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $50,203.50 firm fixed-price purchase order is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- This federal contract award to Nanostring Technologies, Inc. is for the provision of the NANOSTRING HUMAN MIRNA ASSAY KIT, valued at $10,789.01. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2015. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $8,813 firm fixed-price purchase order is for the delivery of AMBIS# 1552919NCOUNTER GX CODESET-48 RXNS GXA-P1CS-048, No. 100021. This order is not associated with a set-aside program. Nanostring has...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $15,366.00 firm fixed-price purchase order contract to Nanostring Technologies, Inc. for the supply of NANOSTRING TECHNOLOGIES INC (AMBIS #2223210) CONSUMABLE XT TAG SETRNA BIOLOGICAL PRODUCTS. This is a non-set-aside contract with an ultimate completion date of August 1, 2024. Nanostring Technologies, Inc. is a publicly traded provider of life science tools and services, including advanced genomic analysis platforms...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nanostring Technologies, Inc. for $65,992.00. The contract is for the delivery of reagents and consumables for Nanostring's existing CosMx Spatial Molecular Imager, a genomic analysis platform used to support biomedical research and healthcare programs across various government agencies. Nanostring Technologies is a publicly held provider of life science...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $125,565.00 firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools for research and diagnostics. The award is for the delivery of nCounter Sprint Profiler instruments, 1D LS Train, Sprint Training Kit, and shipping/handling. This sole-source award was made without a set-aside designation under the...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $6,895.00 firm fixed price purchase order was awarded on May 11, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for AMBIS# 1554864NCOUNTER GX CODESET--48 RXNS GXA-P1CS-048 (136 GEN X 48 RXNS). This contract has no set-aside designation. Nanostring is the prime...
- This $90,793 purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Nanostring Technologies, Inc., a provider of advanced genomic analysis platforms. The contract is for the procurement of consumable fluids for the GeoMx Digital Spatial Profiler, a novel technology that enables spatially-resolved, digital quantification of proteins and RNA in tissue samples. The award is not designated as a set-aside contract....
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Nanostring Technologies, Inc. The $18,660 firm fixed-price purchase order is for the supply of the NANOSTRING MOUSE IMMUNOLOGY KIT, catalog number GXA-MIMI-48. This award was not set aside for any specific business type. Nanostring Technologies is a publicly traded company that specializes in advanced genomic analysis platforms and life science tools for translational research and diagnostics. The company has previously received multiple federal contract awards from agencies such as the USDA, VA, and DHA to provide specialized laboratory equipment, reagents, assays, and research support services. This contract award supports NIAID's biomedical research programs through the supply of Nanostring's proprietary technology, which enables multiplexed analysis of nucleic acids, proteins, and cells.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 9/25/13 |